Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (311-320 of 594) with videos related to

Pageof 60
Sort By:
JACC. Advances|April 26, 2025
Risk of Myocardial Infarction in Patients With Aortic Stenosis: Insights From the VALVENOR RegistryGilles Lemesle, Augustin Coisne, Sandro Ninni, et al.
Scientific Reports|April 30, 2026
A functional variant in the porcine APOA2 promoter alters hepatic gene expression via RORαJunhui Liu, Carles Hernández-Banqué, Olga González-Rodríguez, et al.
Diabetes & Vascular Disease Research|September 25, 2020
Timed physical exercise does not influence circadian rhythms and glucose tolerance in rotating night shift workers: The EuRhythDia studyJuliane Hannemann, Anika Laing, Karin Glismann, et al.
The Journal of Biological Chemistry|June 25, 2003
The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiationCoralie Fontaine, Guillaume Dubois, Yannick Duguay, et al.
The Journal of Biological Chemistry|July 18, 2002
Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasisKaren Meir, Daniel Kitsberg, Irit Alkalay, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 16, 2020
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonistsAurélie Hurtevent, Morgan Le Naour, Veronique Leclerc, et al.
FEBS Letters|July 19, 2005
Transient impairment of the adaptive response to fasting in FXR-deficient miceBertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2008
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluationCécile Parmenon, Jérôme Guillard, Daniel-Henri Caignard, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2025
A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASHJustine Gillard, Martin Roumain, Corinne Picalausa, et al.
Molecular and Cellular Biology|March 27, 2013
Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytesSandrine Caron, Carolina Huaman Samanez, Hélène Dehondt, et al.
Pageof 60

Showing results (311-320 of 594) with videos related to

Sort By:
Pageof 60
JACC. Advances|April 26, 2025
Risk of Myocardial Infarction in Patients With Aortic Stenosis: Insights From the VALVENOR RegistryGilles Lemesle, Augustin Coisne, Sandro Ninni, et al.
Scientific Reports|April 30, 2026
A functional variant in the porcine APOA2 promoter alters hepatic gene expression via RORαJunhui Liu, Carles Hernández-Banqué, Olga González-Rodríguez, et al.
Diabetes & Vascular Disease Research|September 25, 2020
Timed physical exercise does not influence circadian rhythms and glucose tolerance in rotating night shift workers: The EuRhythDia studyJuliane Hannemann, Anika Laing, Karin Glismann, et al.
The Journal of Biological Chemistry|June 25, 2003
The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiationCoralie Fontaine, Guillaume Dubois, Yannick Duguay, et al.
The Journal of Biological Chemistry|July 18, 2002
Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasisKaren Meir, Daniel Kitsberg, Irit Alkalay, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 16, 2020
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonistsAurélie Hurtevent, Morgan Le Naour, Veronique Leclerc, et al.
FEBS Letters|July 19, 2005
Transient impairment of the adaptive response to fasting in FXR-deficient miceBertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2008
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluationCécile Parmenon, Jérôme Guillard, Daniel-Henri Caignard, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2025
A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASHJustine Gillard, Martin Roumain, Corinne Picalausa, et al.
Molecular and Cellular Biology|March 27, 2013
Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytesSandrine Caron, Carolina Huaman Samanez, Hélène Dehondt, et al.
Pageof 60